• From Barrier Biology to Faster Genotyping

  2026-08-14

  Mechanistic studies of Lactobacillus gasseri, NR1I3, and E-cadherin show why genotype-aware model selection matters in translational research. This article connects that biology with a rapid, single-tube PCR workflow for insects, tissues, fishes, and cells while clarifying performance boundaries and validation priorities.

• Fluorouracil: From TS Inhibition to Translation

  2026-08-13

  Fluorouracil, also known as 5-Fluorouracil, remains a powerful translational anchor because its thymidylate synthase mechanism connects molecular pharmacology with measurable replication stress and tumor-cell death. This article links established Fluorouracil (Adrucil) benchmarks to emerging SMC2 and SMC4 findings in breast cancer research, outlines experimental design principles for colon cancer research, and explains why target engagement, exposure control, and biomarker context should guide the next generation of solid-tumor studies.

• PTEN mRNA: From Pathway Repair to Delivery

  2026-08-13

  A translational framework for using EZ Cap™ Human PTEN mRNA to connect PTEN biology, Cap 1 and poly(A) design, nanoparticle delivery, and preclinical cancer research.

• AZD0156: Practical ATM Kinase Inhibitor Workflows

  2026-08-12

  AZD0156 is a highly selective ATM kinase inhibitor for connecting DNA damage signaling with repair, checkpoint, and metabolic phenotypes. This workflow-focused guide covers formulation, target-engagement assays, combination studies, and troubleshooting for cancer therapy research.

• Fluorescence to Translation in Antibody Research

  2026-08-12

  How a Cy3 secondary antibody can strengthen antibody characterization, assay comparability, and translational decision-making in orthopoxvirus research.

• CTOP for μ-Opioid Receptor Research

  2026-08-11

  CTOP provides a selective pharmacological switch for separating μ-opioid receptor effects from downstream circuit activity in binding, signaling, and pain-model experiments. This guide translates recent brain-to-spinal findings into practical assay designs, controls, and troubleshooting strategies for opioid receptor research.

• Neurotensin: Designing Cleaner GPCR Assays

  2026-08-11

  Neurotensin is a powerful perturbation tool for studying NTR1 signaling, receptor recycling, and miR-133α modulation in gastrointestinal cells. This article presents a measurement-aware workflow that connects GPCR biology with fluorescence-interference control without confusing assay methodology with direct mechanistic evidence.

• Capecitabine for Tumor-Stroma Drug Screening

  2026-08-10

  Capecitabine provides a practical way to investigate prodrug activation, tumor–stroma interactions, and treatment resistance in patient-derived models. This workflow shows how to deploy it in gastric assembloids and colon cancer research while separating validated findings from assay-specific optimization.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-09

  Track mRNA uptake and EGFP translation in the same experiment with a dual-fluorescence reporter built for delivery optimization. This practical guide connects Cy5 imaging, functional expression, and LNP benchmarking to faster troubleshooting in macrophage and gene-delivery studies.

• Capecitabine in Patient-Derived Gastric Assembloids

  2026-08-08

  Capecitabine offers a mechanistically informative way to study prodrug activation, stromal effects, and treatment response in patient-derived gastric assembloids. This article translates recent assembloid findings into practical assay decisions for preclinical oncology research while distinguishing evidence from experimental hypotheses.

• Cy5 Hydrazide for Carbonyl Labeling

  2026-08-07

  Cy5 hydrazide is a carbonyl-reactive fluorescent dye for aldehyde and ketone biomolecule labeling, including protein carbonylation labeling and oxidative stress protein detection. Its far-red emission, strong reported extinction coefficient, and compatibility with SDS-PAGE workflows support sensitive carbonyl analysis, while low aqueous solubility requires an organic co-solvent.

• TAK1 Stabilizes YAP to Promote Gastric Cancer Stem Cell Rene

  2026-08-07

  This study elucidates how TGFβ-activated kinase 1 (TAK1) enhances self-renewal and tumorigenic potential in gastric cancer stem cells by stabilizing yes-associated protein (YAP). The findings deepen mechanistic understanding of cancer stem cell maintenance, with implications for targeting chemoresistance and recurrence in solid tumor research.

• Fluorouracil (Adrucil): Reliable Solutions for Solid Tumor A

  2026-08-06

  This article provides a scenario-driven, evidence-based guide to using Fluorouracil (Adrucil) (SKU A4071) in cell viability and cytotoxicity assays for solid tumor research. Drawing on validated protocols, published data, and practical lab experience, it highlights how this reagent delivers reproducible results and addresses common workflow challenges in colon and breast cancer models.

• PSMD14-Driven CARM1 Stabilization Fuels HCC Progression via

  2026-08-06

  This study reveals that PSMD14-mediated deubiquitination stabilizes CARM1, driving proliferation and metastasis in hepatocellular carcinoma (HCC) by upregulating FERMT1 transcription. The findings highlight the CARM1-PSMD14 axis as a promising therapeutic target for HCC intervention.

• Cimetidine in Advanced Blood-Brain Barrier and Cancer Resear

  2026-08-05

  Explore how Cimetidine, a histamine-2 receptor antagonist, is reshaping blood-brain barrier studies and gastrointestinal cancer research. This article uncovers new insights and protocols for leveraging Cimetidine’s unique pharmacology in translational assays.

8072 records 2/539 page Previous Next 12345 下5页 Last page